Brief: Nextcure Presents Initial Data From Clinical Trial Of Nc762 And A Trial In Progress Poster For Nc410 Combo
07/11/2022 13:08
Nov 7 (Reuters) - NextCure Inc NXTC.O :
* NEXTCURE PRESENTS INITIAL DATA FROM CLINICAL TRIAL OF
NC762 AND
A TRIAL IN PROGRESS POSTER FOR NC410 COMBO AT THE 2022 SOCIETY
FOR IMMUNOTHERAPY OF CANCER ANNUAL MEETING
Source text for Eikon: ID:nGNX9Q6Yrd
Further company coverage: NXTC.O
((reuters.briefs@thomsonreuters.com;))
Recent news on NextCure
See all newsBrief: Xcellon Biologics Co Acquires Gmp Manufacturing Facility From Nextcure
NextCure Inc reports results for the quarter ended June 30 - Earnings Summary
NextCure Q2 net loss narrows on lower expenses
Brief: NextCure Q2 Net Income USD -14.892 Million
NextCure Inc expected to post a loss of $1.93 a share - Earnings Preview